Search research articles
Contact Us
Filters
Showing results (11-20 of 44) with videos related to
Page
of 5
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 28, 2016
Evidence-based guidelines support integrated disease management as the optimal model of haemophilia care
S W Pipe, C M Kessler
Nature Biotechnology
|
March 4, 2000
A chamber of hope for hemophilia
S W Pipe, R J Kaufman
Proceedings of the National Academy of Sciences of the United States of America
|
October 29, 1997
Characterization of a genetically engineered inactivation-resistant coagulation factor VIIIa
S W Pipe, R J Kaufman
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 25, 2008
Mild/moderate haemophilia A: new insights into molecular mechanisms and inhibitor development
R d'Oiron, S W Pipe, M Jacquemin
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 9, 2018
Advantage of recombinant von Willebrand factor for peri-operative management in paediatric acquired von Willebrand syndrome
A C Weyand, R Jesudas, S W Pipe
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
December 19, 2009
Prophylactic therapy with Fibrogammin P is associated with a decreased incidence of bleeding episodes: a retrospective study
J Lusher, S W Pipe, S Alexander, et al.
The Journal of Biological Chemistry
|
September 26, 1997
Mutagenesis of a potential immunoglobulin-binding protein-binding site enhances secretion of coagulation factor VIII
M Swaroop, M Moussalli, S W Pipe, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 14, 2004
New high-technology products for the treatment of haemophilia
S W Pipe, J-M Saint-Remy, C E Walsh
Journal of Thrombosis and Haemostasis : JTH
|
April 27, 2007
Gene therapy, bioengineered clotting factors and novel technologies for hemophilia treatment
G F Pierce, D Lillicrap, S W Pipe, et al.
Thrombosis and Haemostasis
|
November 2, 2013
Extending the pharmacokinetic half-life of coagulation factors by fusion to recombinant albumin
H J Metzner, S W Pipe, T Weimer, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 44) with videos related to
Sort By:
Page
of 5
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 28, 2016
Evidence-based guidelines support integrated disease management as the optimal model of haemophilia care
S W Pipe, C M Kessler
Nature Biotechnology
|
March 4, 2000
A chamber of hope for hemophilia
S W Pipe, R J Kaufman
Proceedings of the National Academy of Sciences of the United States of America
|
October 29, 1997
Characterization of a genetically engineered inactivation-resistant coagulation factor VIIIa
S W Pipe, R J Kaufman
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 25, 2008
Mild/moderate haemophilia A: new insights into molecular mechanisms and inhibitor development
R d'Oiron, S W Pipe, M Jacquemin
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 9, 2018
Advantage of recombinant von Willebrand factor for peri-operative management in paediatric acquired von Willebrand syndrome
A C Weyand, R Jesudas, S W Pipe
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
December 19, 2009
Prophylactic therapy with Fibrogammin P is associated with a decreased incidence of bleeding episodes: a retrospective study
J Lusher, S W Pipe, S Alexander, et al.
The Journal of Biological Chemistry
|
September 26, 1997
Mutagenesis of a potential immunoglobulin-binding protein-binding site enhances secretion of coagulation factor VIII
M Swaroop, M Moussalli, S W Pipe, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 14, 2004
New high-technology products for the treatment of haemophilia
S W Pipe, J-M Saint-Remy, C E Walsh
Journal of Thrombosis and Haemostasis : JTH
|
April 27, 2007
Gene therapy, bioengineered clotting factors and novel technologies for hemophilia treatment
G F Pierce, D Lillicrap, S W Pipe, et al.
Thrombosis and Haemostasis
|
November 2, 2013
Extending the pharmacokinetic half-life of coagulation factors by fusion to recombinant albumin
H J Metzner, S W Pipe, T Weimer, et al.
Page
of 5